Beijing Chieftain Control Technology Group (300430) Fair Value & Analysis
Industrials · CN · Market cap 1.4B CNY
Fair value as of: Jul 9, 2026
From 1 valuation models · updated today
Fair value updated Jul 9, 2026 — revised from ¥22.09 to ¥3.29 (−85.1%) since Jun 24, 2026. Share price −19.3% over the past month.
Price vs Fair Value (12 months)
12‑month range ¥4.36 – ¥27.67 · fair‑value band ¥2.45 – ¥4.91 · the ¥4.36 price screens above the ¥3.29 fair value. As of Jul 9, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Beijing Chieftain Control Technology Group (300430) currently trades at ¥4.36, while our model-based Fair Value estimate is ¥3.29 — implying the stock looks roughly 24.5% overvalued today. We read business quality at 28/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
Over the trailing twelve months, Beijing Chieftain Control Technology Group generated revenue of 796M CNY at a net margin of 8.3%. Revenue grew 48.7% year over year. It earns a return on equity of 2.0%. Net debt stands at 375M CNY. Fundamentals as of Jul 9, 2026
Our scenario range runs from ¥2.45 (bear case) to ¥4.91 (bull case); at ¥4.36, the current price sits within that range. For context, the median of 10 Industrials peers we cover trades at -50% fair-value upside — at -25%, 300430 screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 9, 2026. TTM = trailing twelve months.
About the company
Beijing Chieftain Control Technology Group Co., Ltd., together with its subsidiaries, provides integrated intelligent manufacturing system solutions for the biopharmaceutical and pharmaceutical industries in China and internationally. It operates through Automation and Rehabilitation Medical segments. The company offers powder equipment comprising dust-free pulverizing systems, pulsed airflow mixing systems, automatic lifting hopping mixers, dust-free feeding stations, ton bad unloading machines, vacuum conveying equipment, metering and dispensing machines, CIP cleaning units, and dry granulators; aseptic isolation equipment consisting of aseptic isolation dispensing and feeding systems, restricted access isolation systems, negative pressure isolation operating systems, and reactor isolation feeding systems; gas chlorine dioxide sterilization equipment; and intelligent packaging equipment. It also provides valve products, such as diaphragm valve, gate valve, diaphragm gate valve, …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Beijing Chieftain Control Technology Group reported revenue of ¥470M in FY2025 versus ¥915M in FY2021, a compound −15.3%/yr. Reported net income was −¥879M in FY2025.
Is 300430 fairly valued? → Check now
Similar stocks
10 more Specialty Industrial Machinery stocks, each showing price versus our Fair Value estimate (as of Jul 9, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| GE Vernova Inc 1GEV | €967.60 | €212.97 | -78% |
| SIEGY SIEGY | $155.06 | $89.54 | -42% |
| 1SIE 1SIE | €284.30 | €122.46 | -57% |
| SMAWF SMAWF | $307.12 | $176.28 | -43% |
| SMNS SMNS | C$31.76 | C$22.91 | -28% |
| SIE SIE | €279.00 | €140.38 | -50% |
| Schneider Electric S.E. SBGSF | $334.00 | $148.44 | -56% |
| Siemens Energy AG SMEGF | $192.99 | $47.30 | -75% |
| Eaton Corporation ETN | $418.61 | $207.98 | -50% |
| Atlas Copco AB ATCOA | kr 190.60 | kr 165.45 | -13% |
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is Beijing Chieftain Control Technology Group (300430) undervalued?
What is the fair value of 300430?
What is the quality score of 300430?
What is the revenue of Beijing Chieftain Control Technology Group (300430)?
What is the net profit margin of 300430?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.